Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 9Uterine Cervical Dysplasia 3Melanoma 3Breast Neoplasms 3Squamous Intraepithelial Lesions 2Papillomavirus Infections 2HIV Infections 2Condylomata Acuminata 2Vulvar Neoplasms 1Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1Virus Diseases 1Squamous Cell Carcinoma of Head and Neck 1Sexually Transmitted Diseases 1Pigmentation Disorders 1Neoplasms 1Keratosis 1Hemangioma, Capillary 1Glioblastoma 1Breast Neoplasms, Male 1Anus Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Imiquimod 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pigmentation Disorders × Imiquimod × Clear all
NCT00979550 2018-03-22

The Effects of Aldara as an Adjunct to Laser Treatment

University of Kentucky

Phase 2 Terminated
7 enrolled 4 charts

Pigmentation Disorders, Hemangioma, Capillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡